SCHEMBL7612142

SCHEMBL7612142

CC(C)(C)C(=O)Oc1ccc(C(CNC[C@H](O)COc2ccc(O)c(CO)c2)c2ccc(OC(=O)C(C)(C)C)cc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ADRB3 P13945 5/20 0.52
ELANE P08246 1/20 0.43
ADRB2 P07550 10/20 0.41
ADRB1 P08588 4/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
TSHR P16473 1/20 0.40
NFKB1 P19838 1/20 0.40
HIF1A Q16665 1/20 0.40
TDP1 Q9NUW8 1/20 0.39
PMP22 Q01453 1/20 0.39
ABCB1 P08183 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7611650 0.86 ADRB3 (0.58) ADRB3ADRB2ADRB1
SCHEMBL7638769 0.84 ADRB3 (0.71) ADRB3ADRB2ADRB1
SCHEMBL7612145 0.79 ELANE (0.43) ADRB3ELANEADRB2ADRB1CYP1A2
SCHEMBL7610557 0.76 ADRB3 (0.74) ADRB3ADRB2ADRB1ABCB1
SCHEMBL7610759 0.74 ADRB3 (0.57) ADRB3ADRB2ADRB1ABCB1
Hydrochloric Acid SCHEMBL7608362 0.73 ADRB2 (0.50) ADRB3ADRB2ADRB1
SCHEMBL14030801 0.71 ADRB2 (0.59) ADRB3ADRB2ADRB1CYP1A2CYP2D6
SCHEMBL7610387 0.71 ADRB2 (0.46) ADRB3ADRB2ADRB1CYP1A2CYP2D6
SCHEMBL7042590 0.71 ADRB2 (0.56) ADRB3ADRB2ADRB1CYP1A2CYP2D6
SCHEMBL11595152 0.69 PTGS1 (0.68) ADRB3ADRB2ADRB1CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1230210-A1 AMINOALCOHOL DERIVATIVES USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-08-14 EP disclosed
WO-2001036375-A1 AMINOALCOHOL DERIVATIVES USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-05-25 WO disclosed